Keyphrases
ErbB Signaling
100%
Combination Therapy
100%
Prostate Cancer Cells
100%
Hedgehog Signaling
100%
Hormone-sensitive Prostate Cancer
100%
Cancer Cell Growth
100%
Hedgehog Signaling Pathway
50%
Gefitinib
37%
Cyclopamine
37%
ErbB Inhibitor
37%
Lapatinib
37%
Androgen Deprivation Therapy
25%
ErbB Signaling Pathway
25%
Hedgehog Inhibitor
25%
Prostate Cancer
12%
Drug Interactions
12%
Prostate Cancer Metastasis
12%
Antiproliferation
12%
Prostate Radiotherapy
12%
LNCaP
12%
C4-2B
12%
Radical Prostatectomy
12%
Male Cancer
12%
Chemotherapy Protocols
12%
Cancer Mortality
12%
Metastasis
12%
Specific Inhibitor
12%
New Drug Targets
12%
SMO Inhibitor
12%
Circulating Tumor Cells
12%
Isobologram
12%
Hedgehog
12%
Prostate Cancer Patients
12%
Prostate Cancer Cell Lines
12%
Combination Index Method
12%
Cancer Cell Proliferation
12%
ErbB2
12%
Synergistic Effect
12%
Advanced Prostate Cancer
12%
Androgen Independence
12%
Synergistic Chemotherapy
12%
Prostate Cancer Development
12%
Chemotherapy
12%
Signal Transduction Inhibitors
12%
Medicine and Dentistry
Prostate Cancer
100%
Cancer Growth
100%
Combination Therapy
100%
Androgen
100%
ErbB
100%
Cyclopamine
27%
Hedgehog Signaling
27%
Signal Transduction
27%
Gefitinib
27%
Lapatinib
27%
Chemotherapy
18%
Cancer Cell
18%
Metastatic Carcinoma
18%
Epidermal Growth Factor Receptor
9%
Prostate Cancer Cell Line
9%
Drug Interaction
9%
Prostatectomy
9%
Circulating Tumor Cell
9%
Cell Proliferation
9%
Malignant Neoplasm
9%
Cancer Therapy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Combination Therapy
100%
Androgen
100%
Cancer Growth
100%
Hedgehog
100%
Cyclopamine
25%
Gefitinib
25%
Lapatinib
25%
Chemotherapy
16%
Drug Interaction
8%
Neoplasm
8%
Epidermal Growth Factor Receptor
8%
Malignant Neoplasm
8%